In today’s recent session, 1,982,046 shares of the Vascular Biogenics Ltd.(NASDAQ:VBLT) have been traded, and its beta is 0.9. Most recently the company’s share price was $2.43, and it changed around -$0.12 or -0.05% from the last close, which brings the market valuation of the company to $117.58 Million. VBLT at last check was trading at a discount to its 52-week high of $3.09, offering almost -27.16% off that amount. The share price’s 52-week low was $0.9, which indicates that the recent value has risen by an impressive 62.96% since then. We note from Vascular Biogenics Ltd.’s average daily trading volume that its 10-day average is 387.82 Million shares, with the 3-month average coming to 521.58 Million.
Vascular Biogenics Ltd. stock received a consensus recommendation rating of Buy, based on a mean score of 1.8. If we narrow it down even further, the data shows that none out of 4 analysts rate the stock as a Sell; another but none rate it as Overweight. Among the rest, no body recommended VBLT as a Hold, whereas 4 deemed it a Buy, and no one rated it as Underweight. Vascular Biogenics Ltd. is expected to report earnings per share of -$0.14 for the current quarter.
Vascular Biogenics Ltd. (NASDAQ:VBLT): Trading Information Today
Although VBLT has been showing red trend so far today with a performance of -4.71% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of $2.82- on Monday, Feb 22 increased the stock’s daily price by 13.48%. The company’s shares are currently up 0.29% year-to-date, but still down -0.0431 over the last five days. On the other hand, Vascular Biogenics Ltd. (NASDAQ:VBLT) is -0.09% down in the 30-day period. We can see from the shorts that 1.86 Million shares have been sold at a short interest cover period of 0 day(s).
The consensus price target as assigned by Wall Street analysts is $4.44, which translates to bears needing to increase their stock price by 82.72% from its current value. Analyst projections state that VBLT is forecast to be at a low of $3.75 and a high of $5. In order for the stock price to hit the forecast high, the stock would need to surge +105.76% from its current level, while the stock would need to crash 54.32% from its current level to reach the projected low.
Vascular Biogenics Ltd. (VBLT) projections and forecasts
Vascular Biogenics Ltd. share prices are not performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have risen +100.79 percent over the past six months and at a -1.85% annual growth rate that is well below the industry average of 14%. Moreover, analysts have decided to roll up on their fiscal year 2021 revenue estimates. The rating firms predict that it will gain +12.5% in revenue this quarter, and will report an increase of 13.3% in the next quarter. The year-over-year growth rate is expected to be 65.5%, up from the previous year.
Consensus estimates provided by 4 financial analysts predict the company will bring in an average of $220Million in revenue for the current quarter. 2 analysts expect Vascular Biogenics Ltd. to make $250Million in revenue for the quarter ending March 01, 2021. The company’s sales for the same quarters a year ago were $126Million and $366Million respectively. Analysts predict that the company’s current quarter sales will jump, forecast at 74.6%. Forecasts for the next quarter put sales growth at -31.7%.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 10.4%. Vascular Biogenics Ltd. earnings are expected to increase by 12.6% in 2021, but the outlook is negative 0% per year for the next five years.
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.
Vascular Biogenics Ltd. (NASDAQ:VBLT)’s Biggest Investors
Upon looking at major shareholders, it appears that insiders hold 22.99% of Vascular Biogenics Ltd. shares, and 23.82% of them are in the hands of institutional investors. The stock currently has a share float of 30.93%. Vascular Biogenics Ltd. stock is held by 18 institutions, with Morgan Stanley being the largest institutional investor. By Sep 29, 2020, it held 2.74% of the shares, which is about 819.33 Thousand shares worth $999.58 Thousand.
Renaissance Technologies, LLC, with 1.73% or 518.2 Thousand shares worth $979.4 Thousand as of Dec 30, 2020, holds the second largest percentage of outstanding shares.